drugset / Trial / NCT00810108
Lopinavir/Ritonavir (Kaletra) PK in Children
Phase 4
Completed
12 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
American Association of Colleges of Pharmacy · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to compare the pharmacokinetics of lopinavir tablets administered to pediatric patients as either whole or crushed tablets. The study is a randomized,open-label, crossover study of pediatric subjects already taking lopinavir/ritonavir tablets as part of their clinical care. THe investigators hypothesize that lopinavir exposure in pediatric patients will be lower after taking a dose of the tablet formulation, crushed and mixed with pudding or yogurt, as compared to the exposure after taking a dose with tablets swallowed whole.
Timeline
- Start
- 2006-06
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | — | Oral |
| Background | Ritonavir | Other / unclassified | — | Oral |